GARDASIL 9, HPV vaccine granted in females 9 through 45 years of age in China
20/08/2022
On August 30, GARDASIL 9, MSD’s nine-valent human papillomavirus (HPV) vaccine was approved by the China National Medical Products Administration (NMPA) to prevent new indications.